BAPC
LIVE

Serial Number

88157230

Owner

PHOREUS BIOTECHNOLOGY, INC.

Attorney

Crissa A. Cook

First Use Date

Oct 24, 2017

Filing Date

Oct 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BAPC Trademark

Serial Number: 88157230 • Registration: 6257609

BAPC is a trademark filed by PHOREUS BIOTECHNOLOGY, INC. on October 16, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PHOREUS BIOTECHNOLOGY, INC. (5 trademarks)

Olathe, KS 66061

Entity Type: 03

Trademark Details

Filing Date

October 16, 2018

Registration Date

January 26, 2021

First Use Anywhere

October 24, 2017

First Use in Commerce

September 24, 2018

Published for Opposition

August 27, 2019

Goods & Services

Preparations and substances for facilitating delivery of active substances, namely, a drug delivery agent in the form of peptide capsules, microspheres, or nanospheres for delivering nucleic acids, proteins, enzymes, small molecules, therapeutic drugs, organic compounds, plasmids, dyes, nutrients, minerals, colloidal metal, pesticides, insecticides, parasiticides, and fungicides to cells; Peptides for drug delivery, namely, drug delivery agents consisting of peptide capsules, microspheres, or nanospheres containing or attached to active substances that facilitate delivery of a wide variety of pharmaceutical or veterinary preparations; Carriers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of pharmaceutical or veterinary preparations; Diagnostic agents for medical or veterinary purposes, namely, diagnostic agents in the form of peptide capsules, microspheres, or nanospheres containing or attached to imaging agents for medical or veterinary purposes; Peptide-based preparations for destroying vermin; Fungicides; Herbicides; Imaging agents in the form of peptide capsules, microspheres, or nanospheres for medical and veterinary diagnostic purposes, namely, contrasting agents for ultrasound or near-infrared diagnostic imaging, diagnostic radiopharmaceutical agent for use in PET imaging, imaging agents for magnetic resonance imaging (MRI), radiopharmaceutical imaging agents for diagnosing and monitoring cancer

Chemical, biological, and diagnostic reagents and preparations for scientific, medical and veterinary research use; Biological preparations, other than for medical use, namely, for use in biotechnological product development, manufacture of vaccines, drugs and medicines; Biochemical reagents in the form of peptide capsules, microspheres, or nanospheres used for non-medical purposes; Fertilizers for agricultural use; Fertilizers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of horticultural preparations, plant nutrients, and soil amendments

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 26, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 23, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 22, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 12, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 3, 2020 AITU
USE AMENDMENT FILED
Oct 21, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 21, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2019 EXRA
SOU EXTENSION 1 GRANTED
Nov 11, 2019 EX1G
SOU EXTENSION 1 FILED
Nov 11, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 11, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 22, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2019 NONP
ASSIGNED TO LIE
Jul 21, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 31, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 31, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 31, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2018 NWOS
NEW APPLICATION ENTERED
Oct 19, 2018 NWAP